Related Experiment Video
Updated: May 6, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Linking the SWI/SNF complex to prostate cancer
Ryan S Lee1, Charles W M Roberts
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, the Division of Hematology-Oncology, Boston Children's Hospital and the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Aggressive prostate tumors utilize SChLAP1, a long noncoding RNA, to drive cancer progression. SChLAP1 disrupts SNF5, a key component of the SWI/SNF chromatin-remodeling complex, promoting tumor growth.
Area of Science:
- Cancer biology
- Epigenetics
- Prostate cancer research
Background:
- The SWI/SNF chromatin-remodeling complex is frequently altered in various cancers.
- Mutations in SWI/SNF genes are rare in prostate cancer.
- Long noncoding RNAs (lncRNAs) play emerging roles in cancer development.
Purpose of the Study:
- To investigate the role of SChLAP1, a lncRNA overexpressed in aggressive prostate tumors.
- To determine the mechanism by which SChLAP1 contributes to prostate cancer progression.
- To explore the interaction between SChLAP1 and the SWI/SNF complex.
Main Methods:
- Analysis of SChLAP1 expression in prostate tumor samples.
- Biochemical assays to study the interaction between SChLAP1 and SNF5.
- Functional studies in prostate cancer cell lines to assess the impact of SChLAP1 on SWI/SNF activity and tumor growth.
Main Results:
- SChLAP1 is highly expressed in aggressive prostate tumors.
- SChLAP1 directly binds to and disrupts the function of SNF5, a core subunit of the SWI/SNF complex.
- Disruption of SNF5 by SChLAP1 promotes prostate cancer cell proliferation and aggressiveness.
Conclusions:
- SChLAP1 is a novel oncogenic driver in prostate cancer.
- SChLAP1 promotes cancer by interfering with the SWI/SNF chromatin-remodeling complex via SNF5 disruption.
- Targeting SChLAP1 or its interaction with SNF5 may offer new therapeutic strategies for aggressive prostate cancer.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Anaphase Promoting Complex
Abnormal Proliferation
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...